Heather Hamel - Jul 7, 2022 Form 3 Insider Report for INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV)

Role
Chief Legal Officer and GC
Signature
Heather Hamel
Stock symbol
NVIV
Transactions as of
Jul 7, 2022
Transactions value $
$0
Form type
3
Date filed
7/18/2022, 09:31 PM
Next filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NVIV COMMON STOCK 750 Jul 7, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NVIV Stock Option Jul 7, 2022 Common Stock 1 $49,500.00 Direct F1
holding NVIV Stock Option Jul 7, 2022 Common Stock 1 $78,750.00 Direct F1
holding NVIV Stock Option Jul 7, 2022 Common Stock 1 $138,187.50 Direct F1
holding NVIV Stock Option Jul 7, 2022 Common Stock 1 $81,562.50 Direct F1
holding NVIV Stock Option Jul 7, 2022 Common Stock 960 $27.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All the shares underlying this option have vested and are exercisable.
F2 Half of the shares underlying this option vested on 3/18/22 and the other half shall vest on 3/18/23.

Remarks:

Exhibit Index: 24.1 Power of Attorney